These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3084757)

  • 1. The bioavailability of oral nitroglycerin.
    Noonan PK; Benet LZ
    J Pharm Sci; 1986 Mar; 75(3):241-3. PubMed ID: 3084757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets.
    Kwon HR; Green P; Curry SH
    Biopharm Drug Dispos; 1992 Mar; 13(2):141-52. PubMed ID: 1550909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete and delayed bioavailability of sublingual nitroglycerin.
    Noonan PK; Benet LZ
    Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.
    Noonan PK; Benet LZ
    Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroglycerin absorption from transdermal systems: formulation effects and metabolite concentrations.
    Williams RL; Thakker KM; John V; Lin ET; Liang-Gee W; Benet LZ
    Pharm Res; 1991 Jun; 8(6):744-9. PubMed ID: 1905809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of nitroglycerin in rats.
    Yap PS; Fung HL
    J Pharm Sci; 1978 Apr; 67(4):584-6. PubMed ID: 417170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal absorption of nitroglycerin in the rat: avoidance of first-pass metabolism as a function of rectal length exposure.
    Kamiya A; Ogata H; Fung HL
    J Pharm Sci; 1982 Jun; 71(6):621-4. PubMed ID: 6808113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
    Jensen KM; Dahl JB
    Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two nitroglycerin dosage forms: a metered spray and a soft gelatin capsule.
    Erb R; Stoltman W
    J Pharmacokinet Biopharm; 1983 Dec; 11(6):611-21. PubMed ID: 6431075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyceryl-1-nitrate pharmacokinetics in healthy volunteers.
    Laufen H; Leitold M
    Br J Clin Pharmacol; 1987 Mar; 23(3):287-93. PubMed ID: 3105569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of organic nitrates.
    Bogaert MG
    Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nitroglycerin and its dinitrate metabolites over a thirtyfold range of oral doses.
    Nakashima E; Rigod JF; Lin ET; Benet LZ
    Clin Pharmacol Ther; 1990 May; 47(5):592-8. PubMed ID: 2111749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroglycerin stability: effects on bioavailability, assay and biological distribution.
    Sokoloski TD; Wu CC
    J Clin Hosp Pharm; 1981 Dec; 6(4):227-32. PubMed ID: 6802877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
    Lee FW; Salmonson T; Metzler CH; Benet LZ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of nitroglycerin and metabolites in humans following oral dosing.
    Yu DK; Williams RL; Benet LZ; Lin ET; Giesing DH
    Biopharm Drug Dispos; 1988; 9(6):557-65. PubMed ID: 3147725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.